CABP2

Across TCGA pan-cancer cohorts, CABP2 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of CABP2’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where CABP2 RNA is repressed in tumor relative to normal tissue. In most cancer types CABP2 is over-expressed in tumor, although a few such as COAD and KICH show the opposite, repressed pattern.

COAD, KICH, and BRCA are the cancer types where CABP2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CABP2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	−0.135	<.001	10	view →
KICH	All	All	−0.032	.006	3	view →
BRCA	All	III,IV	−0.018	.019	2	view →
KIRC	All	All	−0.011	.029	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

CABP2–COAD

Open the COAD breakdown →